Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors—two key hormones involved in metabolic regulation. Like GLP-1 receptor agonists, it helps reduce appetite, slow digestion, and promote fullness. The additional activation of GIP receptors may further enhance insulin sensitivity and energy balance. Together, these effects contribute to reduced food intake, improved glucose metabolism, and significant weight loss. Tirzepatide represents a broader, more targeted approach to metabolic health and should be used as part of a medically supervised weight management plan.